[hlHome]

0

Back to Resectable Melanoma: Assessing Pathological Response Following Neoadjuvant Treatment
Resectable Melanoma: Assessing Pathological Response Following Neoadjuvant Treatment

Resectable Melanoma: Assessing Pathological Response Following Neoadjuvant Treatment

 

This activity is designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in improving the measurement, scoring, and assessment of pathological response in patients with resectable melanoma undergoing neoadjuvant immunotherapy.

  • List Price: Free
Item Details:

Activity Overview

This activity is designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in improving measurement, scoring, and assessment of pathological response in patients with resectable melanoma undergoing neoadjuvant...

Back to Resectable Melanoma: Assessing Pathological Response Following Neoadjuvant Treatment
View More View Less

Bought This Bought That ...